COVID treatment patent applied for - using Rutin, Vitamin D, Vitamin C, Magnesium, etc. – April 2022

---

Promising therapeutic approach for SARS-CoV-2 infection by using a rutin-based combination therapy

ChemMedChem. 2022 Apr 30. doi: 10.1002/cmdc.202200157 behind paywall
Monika Mazik 1

The development of new therapeutic approaches for SARS-CoV-2 infection is of particular current importance. The combination therapy proposed here is based on already proven, safe compounds. The natural compound rutin, one of the six therapy components, has the potential to inhibit both viral and host cell targets. In addition, this therapy involves the use of acetylsalicylic acid, vitamin C and vitamin D 3 , which should be administered together with calcium and magnesium. The importance of each component is briefly described in this article. Due to multiple anti-infective properties of rutin, it provides a basis for combating SARS-CoV-2 infection as well as various viral and bacterial co-infections observed in patients. There are strong indications for a good effect of this simple combination therapy, especially in the early stages of infection. It has the potential to be of interest both prophylactically and therapeutically, and offers the possibility of protection against severe disease progression.

---

VitaminDWiki - 25 studies in both categories of Virus and Magnesium

This list is automatically updated

---

VitaminDWiki - 25 studies in both categories of Virus and Vitamin C

This list is automatically updated

---

VitaminDWiki - 41 studies in both categories of Virus and Intervention

This list is automatically updated

---

Note: RUTIN is very similar chemically to Quercetin which increases Vitamin D getting to cells

---

VitaminDWiki - Who said vitamin D could not be patented

• Semi-activated Vitamin D given weekly (used by Spanish COVID-19 trial) – US patent application Sept 2020
• Vitamin D patented to treat ADHD – June 2018